Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

No! Biologics only delay surgery8th S-ECCO IBD Masterclass
Year: 2019
Authors: Willem Bemelman
No! Redo pouch is fantastic!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Conor Delaney
No! Surgery is the only solution!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Antonino Spinelli
Non-Pharmacological Interventions in IBDEducational Audio Podcasts
Year: 2019
Authors: Ailsa Hart
Novel dietary treatments for IBD - how to advise the patient4th D-ECCO Workshop
Year: 2019
Authors: Rotem Sigall-Boneh
Nutritional factors in transitional IBD4th D-ECCO Workshop
Year: 2019
Authors: Shameer  Mehta
Oncologic decisions in IBD surgery8th S-ECCO IBD Masterclass
Year: 2019
Authors: Phillip Fleshner
Only medical treatment can solve the problem!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Julián Panés
Open surgery for IBD patients: Never?8th S-ECCO IBD Masterclass
Year: 2019
Authors: Fabrizio Michelassi
Opioids, dysbiosis and worsening gut inflammation - a causal link?JCC Podcast
Year: 2019
Authors: Umakant Sharma et al.

Umakant Sharma reports his work linking prescription opioids with increased gut dysbiosis, alterations in epithelial tight junction function and colitis severity in 2 different murine models of colitis.

Oral Presentation: Challenges in managing the elderlyScientific Programme
Year: 2019
Authors: Guillaume Savoye
Oral Presentation: OP01: In-depth characterization of host-genetics and gut microbiome unravels novel host-microbiome interactions in Inflammatory Bowel DiseaseScientific Programme
Year: 2019
Authors: Shixian Hu
Oral Presentation: OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s DiseaseScientific Programme
Year: 2019
Authors: Chao Li
Oral Presentation: OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairmentScientific Programme
Year: 2019
Authors: Tamas Korcsmaros
Oral Presentation: OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitisScientific Programme
Year: 2019
Authors: Laurent Peyrin-Biroulet
Oral Presentation: OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitisScientific Programme
Year: 2019
Authors: Johanne Brooks
Oral Presentation: OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo cultureScientific Programme
Year: 2019
Authors: Kaline Arnauts
Oral Presentation: OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptakeScientific Programme
Year: 2019
Authors: Roswitha Gropp
Oral Presentation: OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI phase 3 induction studyScientific Programme
Year: 2019
Authors: Katherine Li
Oral Presentation: OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately-to-severely active ulcerative colitis: data from the U-ACHIEVE studyScientific Programme
Year: 2019
Authors: William J. Sandborn